Form4insider filings, from the source

SEC Form 5 · accession 0001493152-18-001602

GALECTIN THERAPEUTICS INC · GALT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Sep 30, 2017
Accepted (ET)
Feb 7, 2018 · 3:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001133416

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Sep 30, 2017J1,000$6.00A889,630D
Common StockF2,F5Sep 30, 2017J119,129$1.93A3,254,279ISee Footnote 5
Common StockF3,F5Dec 31, 2017J111,149$2.07A3,365,428ISee Footnote 5

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses